Yestar Healthcare : DELAY IN PUBLICATION OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020, FURTHER POSTPONEMENT OF BOARD MEETING AND SUSPENSION OF TRADING

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Yestar Healthcare Holdings Company Limited

巨 星 醫 療 控 股 有 限 公 司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2393)

DELAY IN PUBLICATION OF

ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2020

FURTHER POSTPONEMENT OF BOARD MEETING AND

SUSPENSION OF TRADING

This announcement is made by Yestar Healthcare Holdings Company Limited (the ''Company'') pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited Listing Rules (the ''Listing Rules'') and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

DELAY IN PUBLICATION OF ANNUAL RESULTS

Pursuant to Rule 13.49(1) of the Listing Rules, the Company is required to publish its preliminary results for the year ended 31 December 2020 (the ''2020 Annual Results'') no later than 31 March 2021.

The board (the ''Board'') of directors (the ''Directors'') of the Company hereby announces that there will be a delay in the release of the 2020 Annual Results of the Company as the management of the Company is stilling working on and consolidating all supporting documents in respect of the investing and financing projects which has cash flow implication of the Group. Since management of the Company requires more time to have all those documents to prepare and complete the 2020 Annual Results. As such, the Company is unable to publish the 2020 Annual Results by 31 March 2021.

Save for the aforesaid reason, there is no other reason or inside information which lead to the delay in publication of the 2020 Annual Results.

- 1 -

FURTHER POSTPONEMENT OF BOARD MEETING

Reference is made to the announcements of the Company dated 16 March 2021 and 19 March 2021. As additional time is required to complete the 2020 Annual Results, the Board hereby announces that the date of the meeting of the Board to consider and approve, among other things, the 2020 Annual Results of the Company will be postponed to Wednesday, 7 April 2021.

SUSPENSION OF TRADING

As the Company cannot publish the 2020 Annual Results by 31 March 2021, application has been made to The Stock Exchange of Hong Kong Limited for suspension of trading of the shares of the Company with effect from 9 : 00 a.m. on 1 April 2021.

By Order of the Board

Yestar Healthcare Holdings Company Limited

Hartono James

Chairman, CEO and Executive Director

31 March 2021

As at the date of this announcement, the executive Directors are Mr. Hartono James, Ms. Wang Ying, Ms. Wang Hong and Ms. Liao Changxiang; the independent non-executive Directors are Dr. Hu Yiming, Mr. Karsono Tirtamarta (Kwee Yoe Chiang) and Mr. Sutikno Liky.

- 2 -